Back to Search
Start Over
N1,N3-disubstituted uracils as nonnucleoside inhibitors of HIV-1 reverse transcriptase.
- Source :
-
Bioorganic & medicinal chemistry [Bioorg Med Chem] 2013 Mar 01; Vol. 21 (5), pp. 1150-8. Date of Electronic Publication: 2013 Jan 03. - Publication Year :
- 2013
-
Abstract
- A series of phenyloxyethyl and cinnamyl derivatives of substituted uracils were synthesized and found to exhibit potent activity against HIV-RT and HIV replication in cell culture. In general, the cinnamyl derivatives proved superior to the phenyloxyethyl derivatives, however 1-[2-(4-methylphenoxy)ethyl]-3-(3,5-dimethylbenzyl)uracil (19) exhibited the highest activity (EC(50)=0.27 μM) thus confirming that the 3-benzyluracil fragment in the NNRTI structure can be regarded as a functional analogue of the benzophenone pharmacophore typically found in NNRTIs.<br /> (Copyright © 2012 Elsevier Ltd. All rights reserved.)
- Subjects :
- Binding Sites
Cell Line
Cinnamates chemistry
HIV Reverse Transcriptase genetics
HIV Reverse Transcriptase metabolism
HIV-1 drug effects
Humans
Molecular Docking Simulation
Mutation
Protein Structure, Tertiary
Reverse Transcriptase Inhibitors chemical synthesis
Reverse Transcriptase Inhibitors pharmacology
Structure-Activity Relationship
Uracil chemical synthesis
Uracil pharmacology
HIV Reverse Transcriptase antagonists & inhibitors
HIV-1 enzymology
Reverse Transcriptase Inhibitors chemistry
Uracil analogs & derivatives
Subjects
Details
- Language :
- English
- ISSN :
- 1464-3391
- Volume :
- 21
- Issue :
- 5
- Database :
- MEDLINE
- Journal :
- Bioorganic & medicinal chemistry
- Publication Type :
- Academic Journal
- Accession number :
- 23357038
- Full Text :
- https://doi.org/10.1016/j.bmc.2012.12.027